Aza-peptidyl Michael acceptors. A new class of potent and selective inhibitors of asparaginyl endopeptidases (legumains) from evolutionarily diverse pathogens

Journal of Medicinal Chemistry
Marion G GötzJames C Powers

Abstract

Aza-peptide Michael acceptors with the general structure of Cbz-Ala-Ala-AAsn- trans-CH=CHCOR are a new class of inhibitors specific for the asparaginyl endopeptidases (AE) (legumains). Structure-activity relationships (SARs) were characterized for a set of 31 aza-peptide Michael acceptors with AEs derived from three medically important parasites: the protist Trichomonas vaginalis, the hard tick Ixodes ricinus, and the flatworm Schistosoma mansoni. Despite arising from phylogenetically disparate organisms, all three AEs shared a remarkably similar SAR with lowest IC50 values extending into the picomolar range. The results suggest an evolutionary constraint on the topography of the prime side of the active site. SAR also revealed that esters in the P1' position are more potent than disubstituted amides and that monosubstituted amides and alkyl derivatives show little or no inhibition. The preferred P1' residues have aromatic substituents. Aza-asparaginyl Michael acceptors react with thiols, which provides insight into the mechanism of their inhibition of asparaginyl endopeptidases.

References

Jan 1, 1977·Methods in Enzymology·J C Powers, B F Gupton
Nov 13, 1992·Journal of Medicinal Chemistry·J Magrath, R H Abeles
Mar 20, 1992·Journal of Medicinal Chemistry·S Liu, R P Hanzlik
Jan 1, 1986·Journal of Medicinal Chemistry·S A ThompsonR P Hanzlik
Jun 1, 1984·Journal of Medicinal Chemistry·R P Hanzlik, S A Thompson
Aug 18, 1995·Journal of Medicinal Chemistry·J T PalmerD Brömme
Sep 22, 1998·The Biochemical Journal·J M ChenA J Barrett
Sep 29, 1999·Proceedings of the National Academy of Sciences of the United States of America·D A MatthewsS T Worland
Oct 6, 2000·FEBS Letters·N SchaschkeW Machleidt
Aug 15, 2001·Biological Chemistry·V I RotariA J Barrett
Apr 18, 2002·Bioorganic & Medicinal Chemistry Letters·Norbert SchaschkeChristian P Sommerhoff
May 3, 2002·Molecular and Biochemical Parasitology·Mary A MathieuJames H McKerrow
Nov 1, 2002·Journal of Medicinal Chemistry·Juliana L AsgianJames C Powers
Nov 20, 2002·Biological Chemistry·André J NiestrojHans-Ulrich Demuth
Dec 12, 2002·Chemical Reviews·James C PowersKaren Ellis James
Sep 17, 2003·Biological Chemistry·Kylie LoakColin Watts
Apr 2, 2004·Journal of Medicinal Chemistry·Ozlem Doğan EkiciJames C Powers
Apr 24, 2004·Trends in Parasitology·Conor R CaffreyMohammed Sajid
Mar 1, 1996·Parasitology Today·J P Dalton, P J Brindley
Oct 10, 2006·The Journal of Biological Chemistry·Melaine DelcroixJames H McKerrow
Oct 17, 2006·Clinical Microbiology Reviews·Stephen J SwansonEdward A Belongia
Nov 17, 2006·Nature Chemical Biology·Adam R Renslo, James H McKerrow
Mar 6, 2007·International Journal for Parasitology·Daniel SojkaPetr Kopácek

❮ Previous
Next ❯

Citations

Jun 20, 2013·Journal of Molecular Modeling·Akos RáczBéla Noszál
May 15, 2013·Trends in Parasitology·Daniel SojkaPetr Kopáček
Aug 3, 2011·Future Medicinal Chemistry·Caroline ProulxWilliam D Lubell
Jan 5, 2016·Ticks and Tick-borne Diseases·Daniel SojkaPetr Kopáček
Oct 27, 2009·Trends in Parasitology·Holly J AtkinsonMohammed Sajid
Mar 20, 2013·BioMed Research International·Francisco Javier Rendón-GandarillaRossana Arroyo
Mar 23, 2011·Nanomedicine : Nanotechnology, Biology, and Medicine·Debbie LiaoRalph A Reisfeld
Apr 27, 2016·Expert Opinion on Therapeutic Targets·Zhentao ZhangKeqiang Ye
Jun 4, 2016·Chemical Research in Toxicology·Emily N PierceGregory R J Thatcher
Jul 8, 2020·Journal of Enzyme Inhibition and Medicinal Chemistry·Thomas S CorriganÖzlem Doğan Ekici
Jun 18, 2021·Frontiers in Immunology·José T Moreira-FilhoCarolina H Andrade
Jul 22, 2018·Analytical Chemistry·Yue ZhaoGaolin Liang
Oct 2, 2021·The Journal of Organic Chemistry·Jorge Lopez-SanchezJose Berna

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.